Independent report

Use of the AstraZeneca COVID-19 vaccine: JCVI statement, 7 May 2021

Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.

From:
Department of Health and Social Care
Published
7 May 2021

Documents

Use of the AstraZeneca COVID-19 (AZD1222) vaccine: updated JCVI statement, 7 May 2021

HTML

Details

Updated statement from the Joint Committee on Vaccination and Immunisation (JCVI) following reports of an extremely rare adverse event after vaccination with the first dose of the AstraZeneca COVID-19 vaccine.

Updates to this page

Published 7 May 2021

Sign up for emails or print this page

Related content